Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
SCYTHE is the adversary emulation validation and threat intelligence platform for the enterprise cybersecurity market.
RubrYc Therapeutics is a biotechnology company.
Edifice Health is a immunological health and personalized nutrition company offering a novel metric of inflammatory health.
Cofense provides phishing threat management and remediation solutions to the world's leading brands and organizations.
Change Donations is a micro-donation platform helping charities fundraise more efficiently and connect with a younger generation
10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.
Teraki is a driver for scaling of insurance, maintenance and autonomous driving applications by enabling access to more qualitative data.
RiskLens empowers risk officers and CISOs to manage their cyber risk from a business perspective by quantifying it in financial terms
Anomali delivers the leading AI-Powered Security and IT Operations Platform.
Paladin Capital Group has invested in 81 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Paladin Capital Group's top investment sectors include Cyber Security, Biotechnology, Health Care, Security, Risk Management. The firm invests across 24 different industry categories.
Among tracked funding rounds, Anomali received $40.0M in a Series D round. Paladin Capital Group's total known invested capital is $1.5B.
Paladin Capital Group's average investment size is $18.5M across its portfolio of 81 companies.
Recent Paladin Capital Group portfolio additions include SCYTHE, RubrYc Therapeutics, Edifice Health, Cofense, Change Donations. These companies were founded in 2020 or later.